glp 1 receptor agonists for type 2 diabetes GLP-1 are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
10.1111/j.1463-1326.2010.01233.x [DOI] [PubMed] [Google Scholar] 29.Gallwitz B
What stood out to me is how were moving beyond traditional glucose control toward a more holistic metabolic approach
GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment
However, the immediate barriers to adoption of these drugs may lie not in their side effect profile, but rather in the ability of our physicians and healthcare system to accept them
For women, both medications can affect menstrual cycles
